Ardent Health (ARDT) CFO awarded 53,846 RSUs, shares withheld for taxes

Rhea-AI Filing Summary

Ardent Health, Inc. Chief Financial Officer Alfred Lumsdaine reported routine equity compensation activity in common stock. On April 1, 2026, he received a grant of 53,846 shares, representing restricted stock units that vest in three equal installments from April 1, 2026. To cover taxes on RSU vesting, the company withheld 2,510 shares on March 31, 2026 at $8.56 per share and 4,381 shares on April 1, 2026 at $8.67 per share under Rule 16b-3. Following these transactions, he directly holds 319,183 common shares.

Insights

Equity compensation analyst

CFO received RSU grant; share withholdings were routine tax payments, not market sales.

The filing shows CFO Alfred Lumsdaine receiving a grant of 53,846 shares of Ardent Health common stock as restricted stock units. These RSUs vest in three substantially equal annual installments starting on April 1, 2026, contingent on his continued service.

Two F-code transactions totaling 6,891 shares were withheld at prices of $8.56 and $8.67 per share to satisfy tax liabilities upon RSU vesting, consistent with Rule 16b-3. These are non-market dispositions and do not represent open-market selling.

After the grant and tax withholdings, Lumsdaine’s direct ownership increased to 319,183 common shares. The activity is standard executive compensation and tax handling, with no indication of discretionary buying or selling decisions in the market.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider LUMSDAINE ALFRED

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	4,381	$8.67	$38K
Grant/Award	Common Stock	53,846	$0.00	--
Tax Withholding	Common Stock	2,510	$8.56	$21K

Holdings After Transaction: Common Stock — 265,337 shares (Direct)

Footnotes (1)

1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Represents the closing price of the common stock of the Issuer on March 31, 2026. Represents the closing price of the common stock of the Issuer on April 1, 2026. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Key Figures

RSU grant size: 53,846 shares Tax-withheld shares (total): 6,891 shares Tax-withheld shares March 31, 2026: 2,510 shares at $8.56/share +2 more

5 metrics

RSU grant size 53,846 shares Restricted stock units granted on April 1, 2026

Tax-withheld shares (total) 6,891 shares Shares withheld for tax obligations on March 31 and April 1, 2026

Tax-withheld shares March 31, 2026 2,510 shares at $8.56/share Closing price on March 31, 2026 used for withholding

Tax-withheld shares April 1, 2026 4,381 shares at $8.67/share Closing price on April 1, 2026 used for withholding

Shares held after transactions 319,183 shares Direct common stock ownership following reported activity

Key Terms

restricted stock units, Rule 16b-3, tax-withholding disposition, grant, award, or other acquisition

4 terms

restricted stock units financial

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 16b-3 regulatory

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3."

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUMSDAINE ALFRED

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		F		2,510(1)	D	$8.56(2)	269,718	D
Common Stock	04/01/2026		F		4,381(1)	D	$8.67(3)	265,337	D
Common Stock	04/01/2026		A		53,846(4)	A	$0	319,183	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

2. Represents the closing price of the common stock of the Issuer on March 31, 2026.

3. Represents the closing price of the common stock of the Issuer on April 1, 2026.

4. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Ardent Health (ARDT) CFO Alfred Lumsdaine report?

Alfred Lumsdaine reported a grant of 53,846 Ardent Health common shares as restricted stock units and two tax-withholding dispositions totaling 6,891 shares. These transactions relate to equity compensation and tax payments, not open-market buying or selling activity.

How many Ardent Health (ARDT) shares does the CFO hold after these transactions?

After the reported transactions, CFO Alfred Lumsdaine directly holds 319,183 shares of Ardent Health common stock. This reflects the new 53,846-share RSU grant, net of 6,891 shares withheld to cover tax liabilities on vested restricted stock units.

Were any of the Ardent Health (ARDT) insider transactions open-market sales?

No, the filing shows no open-market sales. The F-code transactions covering 6,891 shares are tax-withholding dispositions, where shares were withheld to pay taxes on vested restricted stock units in accordance with Rule 16b-3, rather than discretionary market sales.

What are the terms of the CFO’s new restricted stock units at Ardent Health (ARDT)?

The CFO received 53,846 restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026. Vesting is conditioned on his continued service with Ardent Health through each applicable annual vesting date.

At what prices were Ardent Health (ARDT) shares withheld for the CFO’s tax obligations?

Shares were withheld at $8.56 per share on March 31, 2026 and $8.67 per share on April 1, 2026. These prices represent the closing prices of Ardent Health common stock on those respective dates, used for calculating the tax-withholding share amounts.